A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult Participants

NCT04480736 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped portfolio reprioritization

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: JNJ-64281802 High dose
DRUG: JNJ-64281802 Medium dose
DRUG: JNJ-64281802 Low dose
DRUG: JNJ-64281802 Dosing Regimen X
DRUG: JNJ-64281802 Dosing Regimen Y
DRUG: JNJ-64281802 Dosing Regimen Z

Sponsor

Janssen Research & Development, LLC